Filtered By:
Drug: Tamoxifen
Management: Healthcare Costs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
CONCLUSIONS: TDM-guided dose optimization of tamoxifen is estimated to save costs and increase QALYs for early breast cancer patients.PMID:35020170 | DOI:10.1007/s40261-021-01114-6
Source: Clinical Genitourinary Cancer - January 12, 2022 Category: Cancer & Oncology Authors: C Louwrens Braal Anne Kleijburg Agnes Jager Stijn L W Koolen Ron H J Mathijssen Isaac Corro Ramos Pim Wetzelaer Carin A Uyl-de Groot Source Type: research
